MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company currently focused on developing recombinant KLK1 (DM199) for the treatment of acute...
Federal Reserve Chair Jerome Powell recently signaled an imminent shift in policy, with the likelihood of interest rate cuts on the horizon, possibly...